Procyon Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,535
Closed -$214K 592
2025
Q3
$214K Sell
4,535
-3,817
-46% -$184K 0.01% 475
2025
Q2
$403K Sell
8,352
-3,255
-28% -$166K 0.04% 318
2025
Q1
$644K Buy
11,607
+166
+1% +$8.98K 0.04% 327
2024
Q4
$552K Buy
11,441
+277
+2% +$14.1K 0.04% 311
2024
Q3
$643K Sell
11,164
-114
-1% -$6.16K 0.04% 292
2024
Q2
$547K Buy
11,278
+2,371
+27% +$114K 0.04% 297
2024
Q1
$433K Buy
8,907
+2,190
+33% +$107K 0.03% 350
2023
Q4
$334K Sell
6,717
-2,136
-24% -$104K 0.03% 393
2023
Q3
$475K Sell
8,853
-387
-4% -$20.6K 0.05% 308
2023
Q2
$498K Buy
9,240
+2,175
+31% +$117K 0.06% 273
2023
Q1
$384K Buy
+7,065
New +$344K 0.06% 269
2020
Q3
Sell
-787
Closed -$40K 916
2020
Q2
$40K Buy
787
+98
+14% +$4.76K 0.02% 422
2020
Q1
$30K Sell
689
-759
-52% -$36.3K 0.02% 408
2019
Q4
$73K Buy
+1,448
New +$67.8K 0.04% 299

Other funds holding SNY

Procyon Advisors's SNY Position: Q4 2025 in Review

Procyon Advisors sold out of Sanofi (SNY) in Q4 2025, closing a stake of 4,535 shares — an estimated $214K sold.

Procyon Advisors first reported a position in SNY in Q4 2019 and held it in 14 quarters. The position peaked at $644K in Q1 2025. 757 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

  • Procyon Advisors reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
  • Procyon Advisors sold 4,535 Sanofi shares in Q4 2025, an estimated $214K.
  • Procyon Advisors first reported a position in Sanofi in Q4 2019 and held it in 14 quarters.
  • Procyon Advisors's Sanofi position peaked at $644K in Q1 2025.
  • 757 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Procyon Advisors's 13F filing for Q4 2025, filed 7 Jan 2026.